← All diseases Cancer

Breast cancer (metastatic)

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchEvidence of the highest level only (202)Meta-analysis (28)Randomized trial (137)Systematic review (22)Phase 3 Study (15)Clinical trial (672)Review article (235)Early study (phase 1 or 2) (52)Case report (259)Laboratory or animal research (69)Commentary or editorial (15)Retracted Publication (4) Studies currently recruiting participants only (50)

Filter

Publications and studies (2770)

• Retrospective Analysis of Parameters Affecting Metastatic Breast Cancer. (2023/12/29) ♡
• OSMAC-based Discovery and Biosynthetic Gene Clusters Analysis of Secondary Metabolites from Marine-Derived Streptomyces globisporus SCSIO LCY30. (2023/12/28) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Biological Activities of Molecules Derived from Olea europaea L. Tested In Vitro (2023/12/28) ♡
• The Mutational Spectrum of Pre- and Post-Neoadjuvant Chemotherapy Triple-Negative Breast Cancers. (2023/12/23) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Infiltrative Optic Neuropathy in Advanced Breast Carcinoma. (2023/12/23) ♡
• Neurological mechanism and efficacy of acupuncture for breast cancer-related insomnia: a study protocol for randomized clinical trial. (2023/12/22) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Effects of targeting highly expressed in cancer protein 1 (Hec1) inhibitor INH 1 in breast cancer cell lines In Vitro. (2023/12/20) ♡
• A Comparison of 3D Conformal and Deep Inspiratory Breath Holding vs. 4D-CT Intensity-Modulated Radiation Therapy for Patients with Left Breast Cancer. (2023/12/11) ♡
• Intracellular Delivery of Stabilized Peptide Blocking MTDH-SND1 Interaction for Breast Cancer Suppression. (2023/12/08) ♡
• Study of Biomarker Discordance between Primary and Recurrent Sites and its Clinical Implications in Metastatic Breast Cancer: A Single Institutional Study from India. (2023/12/08) ♡
• Gonadotropin Releasing Hormone agonist (GnRHA) during chemotherapy and post-cancer childbirths - a Nationwide population-based cohort study of 24,922 women diagnosed with cancer in Sweden. (2023/12/07) ♡
• Knowledge, Attitude, and Practice of Breast Cancer Patients Toward Lymphedema Complications: Cross-Sectional Study. (2023/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [Elderly Advanced Breast Cancer Effectively Treated with Locoregional Therapy-A Case Report]. (2023/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [Recurrent Breast Cancer with Bone Metastasis Effectively Treated with Abemaciclib plus Endocrine Therapy-A Case Report]. (2023/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [A Case of Breast Cancer Brain Metastases Successfully Treated with Pembrolizumab Therapy after Disease Progression with Atezolizumab Therapy]. (2023/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [A Case of Complete Remission in a Patient with Synchronous Double Cancers of the Breast and Lung]. (2023/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [A Case of Recurrent Breast Cancer That Was BRCA1 Pathogenic Variant-Positive Successfully Treated with PARP Inhibitor]. (2023/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [A Case of Breast Cancer Complicated by Fibrous Dysplasia That Was Difficult to Differentiate from Bone Metastasis]. (2023/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Merkel Cell Carcinoma of Unknown Primary Origin. (2023/12/01) ♡
• The prevalence and clinical significance of HER2 expression in prostate adenocarcinoma. (2023/12/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Factors Associated with the Nutritional Status of Women with Non-Metastatic Breast Cancer at a Brazilian High Complexity Oncology Center. (2023/11/29) ♡
• n-3 PUFAs synergistically enhance the efficacy of doxorubicin by inhibiting the proliferation and invasion of breast cancer cells. (2023/11/28) ♡
• A Multicenter Phase 2 Trial Evaluating the Efficacy and Safety of Preoperative Lenvatinib Therapy for Patients with Advanced Hepatocellular Carcinoma (LENS-HCC Trial). (2023/11/28) ♡
• Breast screening practices of 35-65 years old women - A cross-sectional survey in Alappuzha, Kerala, India. (2023/11/27) ♡
• Treatment pattern and outcomes of leptomeningeal carcinomatosis in India - a retrospective study. (2023/11/27) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. The Utility of Ultrasound-Guided Tru-cut Biopsy in the Diagnosis of Occult Breast Carcinoma Presenting as Ovarian Malignancy with Multiple Metastases: A Case of Unknown Primary. (2023/11/24) ♡
• Benzothiazole Phthalimide Hybrids as Anti-Breast Cancer and Antimicrobial Agents. (2023/11/23) ♡
• A Whole Food, Plant-Based Randomized Controlled Trial in Metastatic Breast Cancer: Feasibility, Nutrient, and Patient-Reported Outcomes. (2023/11/21) ♡
• LUCIA-15 - a real-world prospective study of PARP inhibitors for the treatment of patients with HER-2 negative metastatic breast cancer with germline and/or somatic mutation of BRCA genes or homologous recombination repair related genes. (2023/11/21) ♡
• Polycomb repressor complex 2 suppresses interferon-responsive MHC-II expression in melanoma cells and is associated with anti-PD-1 resistance. (2023/11/20) ♡
• Prognostic Factors Associated With Overall Survival in Breast Cancer Patients With Metastatic Spinal Disease. (2023/11/16) ♡
• Personalized surveillance and aftercare for non-metastasized breast cancer: the NABOR study protocol of a multiple interrupted time series design. (2023/11/14) ♡
• Different Modes of Mechanism of Gamma-Mangostin and Alpha-Mangostin to Inhibit Cell Migration of Triple-Negative Breast Cancer Cells Concerning CXCR4 Downregulation and ROS Generation. (2023/11/10) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Hyperparathyroidism-induced secondary osteoporosis leading to recurrent non-traumatic vertebral compression fractures: A comprehensive case report. (2023/11/10) ♡
• A Whole-Food, Plant-Based Randomized Controlled Trial in Metastatic Breast Cancer: Weight, Cardiometabolic, and Hormonal Outcome. (2023/11/08) ♡
• CD36 maintains lipid homeostasis via selective uptake of monounsaturated fatty acids during matrix detachment and tumor progression. (2023/11/07) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Role of indoleamine 2, 3-dioxygenase 1 in immunosuppression of breast cancer. (2023/11/07) ♡
• Patterns of de novo metastasis and survival outcomes by age in breast cancer patients: a SEER population-based study. (2023/11/06) ♡
• Targeting LINC00152 activates cAMP/CA (2+) /ferroptosis axis and overcomes tamoxifen resistance in ER+ breast cancer. (2023/11/05) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Evaluating differences in optical properties of indolent and aggressive murine breast tumors using quantitative diffuse reflectance spectroscopy. (2023/11/02) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Natural products derived from medicinal plants and microbes might act as a game-changer in breast cancer: a comprehensive review of preclinical and clinical studies. (2023/11/01) ♡
• Changes in leukoencephalopathy and serum neurofilament after (neo) adjuvant chemotherapy for breast cancer. (2023/11/01) ♡
• Para-toluenesulfonamide, a novel potent carbonic anhydrase inhibitor, improves hypoxia-induced metastatic breast cancer cell viability and prevents resistance to αPD-1 therapy in triple-negative breast cancer. (2023/11/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Therapeutic Potential of 1,8-Dihydroanthraquinone Derivatives for Breast Cancer. (2023/10/31) ♡
• Inetetamab combined with pyrotinib and oral vinorelbine for patients with human epidermal growth factor receptor 2 positive advanced breast cancer: A single-arm phase 2 clinical trial. (2023/10/30) ♡
• Effect of a lifestyle intervention program on breast cancer survivors' cardiometabolic health: Two-year follow-up. (2023/10/29) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Navigating next-generation HR (+) /HER2 (-) metastatic breast cancer therapies: a critical commentary on abemaciclib vs. tucidinostat after palbociclib progression. (2023/10/23) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Abemaciclib-based therapy versus tucidinostat-based therapy in patients with HR (+) HER2 (-) metastatic breast cancer after palbociclib progression: insights and challenges from a comparative cohort study in China. (2023/10/23) ♡
• Breast Cancer and Bone Mineral Density in a U.S. Cohort of Middle-Aged Women: Associations with Phosphate Toxicity. (2023/10/21) ♡
• Prehabilitation in an Integrative Medicine Day Clinic for Patients Undergoing Neoadjuvant Treatment: Single-Center Feasibility Pilot Study. (2023/10/18) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.